| Financial Year |
March 31 2023 |
| Monetary Funds |
708,927,742.14 |
| Held-for-trading Financial Assets |
491,283,964.55 |
| Notes Receivable |
16,400,332.21 |
| Accounts Receivable |
782,234,414.25 |
| Advances to Suppliers |
62,279,142.00 |
| Other Receivables |
91,073,025.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
480,708,066.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
53,477,000.00 |
| Other Current Assets |
242,359,239.57 |
| Total Current Assets |
2,971,590,104.71 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
57,759,565.71 |
| Investment Properties |
-- |
| Fixed Assetes |
599,939,650.31 |
| Under-construction Projects |
3,203,539.82 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
169,201,162.20 |
| R&D expenses |
-- |
| Goodwill |
39,026,492.10 |
| Long-Term Deferred and Prepaid Expenses |
1,666,087.39 |
| Deferred Income Tax Assets |
46,258,860.79 |
| Other Non-Current Assets |
9,843,596.51 |
| Sub-Total of Non-Current Assets |
981,533,099.09 |
| Total Assets |
3,953,123,203.80 |
| Short-Term Loans |
170,089,833.33 |
| Trading Financial liabilities |
1,640,666.99 |
| Notes Payable |
185,691,992.27 |
| Accounts Payable |
267,674,643.55 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
14,829,517.43 |
| Taxes Payable |
22,473,438.32 |
| Interest Payable |
-- |
| Dividend Payable |
811,926.50 |
| Other payables |
149,492,616.28 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
16,101,017.27 |
| Other Current Liabilities |
43,211,650.04 |
| Sub-Total of Current Liabilities |
1,050,421,255.83 |
| Long-term Loans |
138,210,142.94 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,260,322.19 |
| Deferred Income Tax Liabilities |
10,001,482.15 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
235,476,237.84 |
| Total Liabilities |
1,285,897,493.67 |
| Paid-In Capital(Or Share Stock) |
535,406,672.00 |
| Capital Surplus |
1,020,096,209.45 |
| Surplus Reserve |
154,323,021.09 |
| LESS:Treasury Stock |
29,376,977.00 |
| Undistributed Profits |
939,726,659.34 |
| Minority Stockholder's Interest |
46,192,256.85 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,621,033,453.28 |
| Owner's Equity（Stockholder's Equity） |
2,667,225,710.13 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,953,123,203.80 |
